Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma [14]

Acta Dermato-Venereologica

Volumn 81, Issue 3, 2001, Pages 224-

  Kreuter, A ^a   Gambichler, T ^a   Schlottmann, R ^a   Altmeyer, P ^a   Brockmeyer, N ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; DOXORUBICIN; FLUOCORTOLONE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; SAQUINAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; DRUG INDUCED DISEASE; ENCAPSULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LETTER; MALE; PRIORITY JOURNAL; PUSTULE; RASH; SKIN ALLERGY; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC AGENTS; DOSAGE FORMS; DOXORUBICIN; DRUG CARRIERS; DRUG ERUPTIONS; HUMANS; LIPOSOMES; MALE; POLYETHYLENE GLYCOLS; SARCOMA, KAPOSI;

EID: 17944377316     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155501750376456     Document Type: Letter

References (4)

1. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma
2. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
3. Safety aspects of pegylated liposomal doxorubicin in patients with cancer
4. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy